BioPharma Services Receives Pharma Tech Outlook Top 10 CRO’s of 2022 Award
TORONTO, ON, April 28, 2022 – BioPharma Services Inc. is delighted to announce the acceptance of the Pharma Tech Outlook Top CRO’s of 2022 award. Pharma Tech Outlook is a print and digital magazine that provides a knowledge network for scaling pharma technology companies. Pharma Tech Outlook has been a pioneer in bringing forth real-world solutions, news, product trends and solutions to its subscribers. BioPharma Services has had the opportunity to be featured in their latest Pharma Tech Outlook Publication, focusing on the top Clinical Research Organizations (CRO’s) of 2022.
Pharma Tech sits down with Anna Taylor, Executive VP of Commercial Operations at BioPharma Services and Dr. Fathi Abuzgaya, one of the founding members of BioPharma Services. In their interview, they discuss the many clinical successes that have been made possible at BioPharma over the years. Both Ms. Anna Taylor and Dr. Fathi Abuzgaya discuss the present and future direction BioPharma Services is taking to not only expand, but strengthen its presence in the global CRO market.
Click Here to read the full article, found on page 18.
About BioPharma Services Inc.
BioPharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in the conduct of Phase 1/2a and Bioequivalence clinical trials for international pharmaceutical companies worldwide. BioPharma Services has clinical research facilities both in the USA and Canada with a total capacity of 300 beds with access to healthy volunteers and special populations. Headquartered in Toronto, Canada, BioPharma’s comprehensive services also include Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Data Management and Medical Writing. For more information about BioPharma Services, please contact Ms. Anna Taylor, EVP of Commercial Operations at ataylor@biopharmaservices.com